Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
作者:
主题词
动物(Animals);主动脉(Aorta);结合, 竞争性(Binding, Competitive);细胞分化(Cell Differentiation);细胞, 培养的(Cells, Cultured);趋化作用(Chemotaxis);胶原(Collagen);复方合剂(Drug Combinations);胚胎, 哺乳动物(Embryo, Mammalian);内皮, 血管(Endothelium, Vascular);女(雌)性(Female);基因表达调控(Gene Expression Regulation);硫酸乙酰肝素(Heparitin Sulfate);人类(Humans);免疫印迹法(Immunoblotting);免疫沉淀法(Immunoprecipitation);层黏连蛋白(Laminin);小鼠(Mice);小鼠, 裸(Mice, Nude);新生血管化, 生理性(Neovascularization, Physiologic);神经纤毛蛋白质1(Neuropilin-1);磷酰化(Phosphorylation);蛋白质结合(Protein Binding);蛋白聚糖类(Proteoglycans);信号传导(Signal Transduction);猪(Swine);酪氨酸(Tyrosine);血管内皮生长因子A(Vascular Endothelial Growth Factor A);血管内皮生长因子受体2(Vascular Endothelial Growth Factor Receptor-2)
DOI
10.1158/0008-5472.CAN-07-6577
PMID
18559514
发布时间
2022-03-09
- 浏览31

Cancer research
4683-92页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文